Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis - Kristen, Arnt; Biener, Moritz; Hegenbart, Ute; Hardt, Stefan; Schnabel, Philipp Albert; Röcken, Christoph; Schönland, Stefan; Katus, Hugo; Giannitsis, Evangelos (International journal of cardiology, 2014)
Gesehen am 06.07.2020